Preoperative prediction of p53 overexpression in pituitary neuroendocrine tumors using MRI radiomics

利用MRI放射组学进行垂体神经内分泌肿瘤p53过表达的术前预测

阅读:1

Abstract

BACKGROUND: The expression of p53 protein is closely related to tumor prognosis and plays an important role in patients with pituitary neuroendocrine tumors (PitNETs). However, its evaluation currently relies on postoperative histopathological analysis. Developing a non-invasive method to predict p53 overexpression preoperatively may help support clinical judgment and facilitate individualized treatment strategies. METHODS: Clinical and imaging data from 186 patients with pathologically confirmed PitNETs were retrospectively collected. The cohort was divided into training and testing sets using stratified random sampling. Radiomic features were extracted from MRI sequences, and feature selection was performed using the intraclass correlation coefficient (ICC) and least absolute shrinkage and selection operator (LASSO). A radiomics score was calculated, and univariate and multivariate logistic regression analyses were used to identify independent clinical risk factors. A combined nomogram model incorporating clinical and radiomic features was constructed. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), precision-recall (PR) curve, calibration curve, and decision curve analysis (DCA). RESULTS: Four radiomic features and two clinical features were selected for model development. Age (odds ratio [OR] = 0.97, 95% confidence interval [CI]: 0.94-0.99, p = 0.01) and suprasellar invasion (OR = 0.47, 95% CI: 0.25-0.89, p = 0.02) were identified as independent predictors of p53 positivity. The combined clinical-radiomic model achieved good predictive performance with an AUC of 0.77 in the validation set, demonstrating favorable discrimination, calibration, and clinical utility. CONCLUSION: The proposed MRI-based radiomics model, integrating clinical and imaging features, enables non-invasive preoperative prediction of p53 overexpression in PitNETs. This approach offers a promising tool for individualized risk stratification and personalized treatment planning in neurosurgical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。